They were starting to get traction in Europe after being in France for 12 months and then exited due to cost. UK started to get traction as well but they stopped before getting the paediatric indication to have it in all ambulance and emergency services. They were due to have a new integrated device called selfie but stopped development on it. It seems on the surface that the strategic review the new team did has resulted in a lot of stopping and not much starting. I am hopeful we will soon get some communication on what the new way forward is , maybe it is a sale !!
Been in this stock a very very longtime and seen the bad times seen the good times but the present is very bleak and I am totally underwater despite earlier cheap purchases and having been well up most of the journey.
Definitely need communication on what is going on and can’t believe they are meeting obligations around keeping the market fully informed.
Ann: Appendix 4C & Quarterly Activity Report - 31 March 2024, page-41
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.005(1.11%) |
Mkt cap ! $51.25M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.0¢ | 44.0¢ | $19.9K | 44.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44643 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.57pm 08/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |